Cite
HARVARD Citation
Sigthorsson, G. et al. (n.d.). COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin. Gut. pp. 527-532. [Online].